A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity
暂无分享,去创建一个
Arthur Christopoulos | Nathan E Hall | Patrick M Sexton | K. Gregory | P. Sexton | A. Christopoulos | M. Lew | N. E. Hall | P. Scammells | C. Valant | Karen J Gregory | Peter J Scammells | Celine Valant | Michael J Lew
[1] Kurt Kristiansen,et al. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. , 2004, Pharmacology & therapeutics.
[2] N. Birdsall,et al. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.
[3] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[4] Xavier Deupi,et al. Probing the β2 Adrenoceptor Binding Site with Catechol Reveals Differences in Binding and Activation by Agonists and Partial Agonists* , 2005, Journal of Biological Chemistry.
[5] A. Christopoulos,et al. Transducer abstraction: a novel approach to the detection of partial agonist efficacy in radioligand binding studies. , 2000, Journal of pharmacological and toxicological methods.
[6] A. Christopoulos,et al. Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors. , 1997, European journal of pharmacology.
[7] F. Ehlert,et al. Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15 , 2007, Journal of Pharmacology and Experimental Therapeutics.
[8] L. Bačáková,et al. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. , 1995, The Journal of pharmacology and experimental therapeutics.
[9] P. Jeffrey Conn,et al. N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] Arthur Christopoulos,et al. Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands* , 2007, Journal of Biological Chemistry.
[11] A. Roszkowski,et al. STRUCTURE-ACTIVITY RELATIONSHIPS AMONG A SERIES OF ACETYLENIC CARBAMATES RELATED TO McN-A-343 , 1967 .
[12] P. Sexton,et al. Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. , 2007, Trends in pharmacological sciences.
[13] A. Christopoulos,et al. Qualitative and quantitative assessment of relative agonist efficacy. , 1999, Biochemical pharmacology.
[14] Arthur Christopoulos,et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.
[15] S. Lazareno,et al. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. , 1995, Molecular pharmacology.
[16] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[17] H. Tecle,et al. Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists. , 1995, Life sciences.
[18] R. Abagyan,et al. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.
[19] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[20] C. Langmead,et al. Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors , 2007, Molecular Pharmacology.
[21] C. Langmead,et al. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox. , 2006, Trends in pharmacological sciences.
[22] J. Wess. Allosteric Binding Sites on Muscarinic Acetylcholine Receptors , 2005, Molecular Pharmacology.
[23] A. Christopoulos. Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log. , 1998, Trends in pharmacological sciences.
[24] C. Guenet,et al. Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site. , 1999, European journal of pharmacology.
[25] P. Leff,et al. Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model‐fitting approach , 1993, British journal of pharmacology.
[26] Arthur Christopoulos,et al. Allosteric modulation of G protein-coupled receptors. , 2007, Annual review of pharmacology and toxicology.
[27] A. Roszkowski. An unusual type of sympathetic ganglionic stimulant. , 1961, The Journal of pharmacology and experimental therapeutics.
[28] M. Waelbroeck. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. , 1994, Molecular pharmacology.
[29] T. Kenakin,et al. G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.
[30] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[31] E. Hulme,et al. The effect of McN‐A‐343 on muscarinic receptors in the cerebral cortex and heart , 1983, British journal of pharmacology.
[32] J. Saldanha,et al. Seven-transmembrane receptors: crystals clarify. , 2002, Trends in pharmacological sciences.
[33] E. Kostenis,et al. Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors. , 1996, European journal of pharmacology.
[34] J. Black. Drugs from emasculated hormones: the principle of syntopic antagonism. , 1989, Bioscience reports.